Related Experiment Video
Updated: Feb 19, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer
Wenjun Wang1,2, Minzhang Guo1, Xiaojun Xia1
1State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Abstract:
X-ray radiation resistance associated 1 (XRRA1) has been found to regulate the response of human tumor and normal cells to X-radiation (XR). Although XRRA1 overexpression is known to be involved in cancer cell response to XR, there are no reports about whether the expression of XRRA1 in tumors can adjust radioresistance. It is widely known that cell cycle arrest could cause radioresistance. We found that blocked XRRA1 expression could lead to cell cycle G2/M arrest by the regulation of cyclin A, cyclin E, and p21 proteins in colorectal cancer (CRC) and expression of XRRA1 reduced cell cycle arrest and increased cell proliferation in CRC. However, whether regulation of the cell cycle by XRRA1 can influence radioresistance is poorly characterized. Correspondingly, DNA repair can effectively lead to radioresistance. In our study, when cancer cells were exposed to drugs and ionizing radiation, low expression of XRRA1 could increase the phosphorylation of DNA repair pathway factors CHK1, CHK2, and ATM and reduce the expression of γ-H2AX, which is believed to participate in DNA repair in the nucleus. Crucially, our results identify a novel link between XRRA1 and the ATM/CHK1/2 pathway and suggest that XRRA1 is involved in a DNA damage response that drives radio- and chemoresistance by regulating the ATM/CHK1/2 pathway.
Insights
X-ray radiation resistance associated 1 (XRRA1) regulates colorectal cancer cell proliferation and DNA repair. Low XRRA1 expression increases radioresistance by affecting cell cycle arrest and DNA damage response pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- X-ray radiation resistance associated 1 (XRRA1) influences cellular responses to X-radiation (XR).
- The role of XRRA1 expression in tumor radioresistance is not well understood.
- Cell cycle arrest and DNA repair are known mechanisms conferring radioresistance.
Purpose of the Study:
- To investigate the role of XRRA1 in regulating colorectal cancer (CRC) cell proliferation and radioresistance.
- To determine the molecular mechanisms by which XRRA1 affects cell cycle progression and DNA damage response.
Main Methods:
- Analysis of XRRA1 expression in CRC cells.
- Investigation of XRRA1's impact on cell cycle regulators (cyclin A, cyclin E, p21).
- Assessment of DNA repair pathway activation (ATM, CHK1, CHK2, γ-H2AX) following radiation and drug exposure.
Main Results:
- Blocked XRRA1 expression induced G2/M cell cycle arrest in CRC cells.
- XRRA1 expression reduced cell cycle arrest and enhanced cell proliferation in CRC.
- Low XRRA1 expression increased DNA repair pathway activation (ATM/CHK1/2 phosphorylation) and reduced γ-H2AX expression.
Conclusions:
- XRRA1 plays a critical role in regulating colorectal cancer cell proliferation.
- XRRA1 is involved in DNA damage response pathways, influencing radioresistance.
- XRRA1 modulates the ATM/CHK1/2 pathway, contributing to radio- and chemoresistance in cancer cells.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Restarting Stalled Replication Forks
Homologous Recombination

